-
Signature
-
/s/ Arthur Reinstein, Attorney-in-Fact
-
Stock symbol
-
CBOE
-
Transactions as of
-
Feb 19, 2025
-
Transactions value $
-
$9,061
-
Form type
-
4
-
Date filed
-
2/21/2025, 04:40 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
CBOE |
Common Stock |
Options Exercise |
$579K |
+2.75K |
+34.31% |
$210.25 |
10.8K |
Feb 19, 2025 |
Direct |
|
transaction |
CBOE |
Common Stock |
Tax liability |
-$265K |
-1.26K |
-11.7% |
$210.25 |
9.52K |
Feb 19, 2025 |
Direct |
|
transaction |
CBOE |
Common Stock |
Options Exercise |
$160K |
+760 |
+7.99% |
$210.25 |
10.3K |
Feb 19, 2025 |
Direct |
|
transaction |
CBOE |
Common Stock |
Tax liability |
-$72.1K |
-343 |
-3.34% |
$210.25 |
9.93K |
Feb 19, 2025 |
Direct |
|
transaction |
CBOE |
Common Stock |
Options Exercise |
$771K |
+3.67K |
+36.89% |
$210.25 |
13.6K |
Feb 19, 2025 |
Direct |
|
transaction |
CBOE |
Common Stock |
Tax liability |
-$341K |
-1.62K |
-11.94% |
$210.25 |
12K |
Feb 19, 2025 |
Direct |
|
transaction |
CBOE |
Common Stock |
Options Exercise |
$645K |
+3.07K |
+25.63% |
$210.25 |
15K |
Feb 19, 2025 |
Direct |
|
transaction |
CBOE |
Common Stock |
Tax liability |
-$286K |
-1.36K |
-9.04% |
$210.25 |
13.7K |
Feb 19, 2025 |
Direct |
|
transaction |
CBOE |
Common Stock |
Sale |
-$77.6K |
-375 |
-2.74% |
$207.05 |
13.3K |
Feb 20, 2025 |
Direct |
F1, F2 |
transaction |
CBOE |
Common Stock |
Sale |
-$750K |
-3.6K |
-27.05% |
$208.45 |
9.71K |
Feb 20, 2025 |
Direct |
F1, F3 |
transaction |
CBOE |
Common Stock |
Sale |
-$353K |
-1.68K |
-17.34% |
$209.43 |
8.03K |
Feb 20, 2025 |
Direct |
F1, F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
CBOE |
Restricted Stock Units |
Options Exercise |
$0 |
-2.75K |
-100% |
$0.00 |
0 |
Feb 19, 2025 |
Common Stock |
2.75K |
|
Direct |
F5, F6 |
transaction |
CBOE |
Restricted Stock Units |
Options Exercise |
$0 |
-760 |
-100% |
$0.00 |
0 |
Feb 19, 2025 |
Common Stock |
760 |
|
Direct |
F5, F6 |
transaction |
CBOE |
Restricted Stock Units |
Options Exercise |
$0 |
-3.67K |
-50% |
$0.00 |
3.67K |
Feb 19, 2025 |
Common Stock |
3.67K |
|
Direct |
F5, F7 |
transaction |
CBOE |
Restricted Stock Units |
Options Exercise |
$0 |
-3.07K |
-33.33% |
$0.00 |
6.14K |
Feb 19, 2025 |
Common Stock |
3.07K |
|
Direct |
F5, F8 |
transaction |
CBOE |
Restricted Stock Units |
Award |
$0 |
+8.18K |
|
$0.00 |
8.18K |
Feb 19, 2025 |
Common Stock |
8.18K |
|
Direct |
F5, F9 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: